Back to search

University of British Columbia

Lipid nanoparticles for delivery of bioactive molecules

Abstract

dc:description

Nanoparticle drug delivery vehicles can be used for in vivo delivery of a variety of bioactive molecules including nucleic acid polymers and small molecule drugs for applications ranging from gene therapy to improving the efficacy of anticancer drugs. This thesis explores different variations of lipid nanoparticles (LNP) formulated with microfluidic mixing method, for encapsulation of a wide range of bioactive agents. The first part of the thesis focuses on the effect of cationic lipid content of the LNP and its effect on encapsulation of negatively charged small cargo. The ability of the rapid mixing/cationic lipid protocol to encapsulate small negatively charged molecules and short oligonucleotides in LNP systems containing ionizable cationic lipids and/or permanently positively charged cationic lipids is explored. It was found that encapsulation of small cargo is dependent on molecule size and charge and that permanently charged LNP are more efficacious at encapsulating small, charged cargo than ionizable LNP. It is also shown that charged prodrug forms of molecules that are neutral in their native form can be encapsulated and delivered using this method. The results of these studies can be used as general guidelines for entrapment and delivery of novel bioactive molecules that are typically difficult to formulate. While the cationic lipid plays an obvious role in entrapment and delivery of negatively charged molecules, the role of helper lipids is not very clear. The second chapter of the thesis looks at the effect of helper lipid titration and variation in in vitro cellular uptake and knockdown and in vivo hepatocyte gene silencing, using ionizable-LNP containing siRNA. It was found that while in vitro knockdown might not be greatly affected when the conventional 10 mol% DSPC (1,2-distearoyl-sn-glycero-3-phosphocholine) is varied, in vivo hepatocyte gene silencing was almost fully disrupted by helper lipid variations. The results of these studies could lead to a more targeted LNP simply by varying the helper lipid that enables avoiding certain cell types or targets specific tissues.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Biochemistry and Molecular Biology
Grantor dc:publisher
University of British Columbia
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ordobadi, Mina

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/72412

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Ordobadi, Mina. Lipid nanoparticles for delivery of bioactive molecules. doctoral thesis, University of British Columbia, 2019. http://hdl.handle.net/2429/72412